NeuroSense Therapeutics Ltd. (NRSN)
NCM · Common · CUSIP M74240108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NRSN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
M74240108
Market Cap
Micro Cap
IPO
12/9/2021 · $6.00/unit
Business: NeuroSense Therapeutics Ltd. is a clinical-stage biopharmaceutical company, focusing on the discovery and development of targeted innovative therapeutics for neurodegenerative diseases.

Company Contact

CEO
Alon Ben-Noon
CFO
Or Eisenberg
Investor Relations
info@neurosense-tx.com
SEC EDGAR Filings
View filings »